Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation

2015 ◽  
Vol 262 (12) ◽  
pp. 2739-2744 ◽  
Author(s):  
P. Krause ◽  
N. Brüggemann ◽  
S. Völzmann ◽  
A. Horn ◽  
A. Kupsch ◽  
...  
2018 ◽  
Vol 117 ◽  
pp. 280-283 ◽  
Author(s):  
Rongsong Zhou ◽  
Yu Ma ◽  
Wei Liu ◽  
Suhua Miao ◽  
Yuqi Zhang

Neurology ◽  
2007 ◽  
Vol 68 (6) ◽  
pp. 457-459 ◽  
Author(s):  
S. W. Hung ◽  
C. Hamani ◽  
A. M. Lozano ◽  
Y-Y W. Poon ◽  
P. Piboolnurak ◽  
...  

2019 ◽  
Vol 34 (4) ◽  
pp. 586-588 ◽  
Author(s):  
Marie-Laure Welter ◽  
Jean-Luc Houeto ◽  
Yulia Worbe ◽  
Mamadou Hassimiou Diallo ◽  
Andreas Hartmann ◽  
...  

2020 ◽  
pp. 185-194
Author(s):  
Mitesh Lotia

The past two decades have revealed substantial benefits of bilateral pallidal deep brain stimulation (DBS) in patients with medication-refractory primary dystonia. There is a growing body of evidence now describing not only short-term but also long-term benefits up to 10 years following DBS. These benefits are often sustained, requiring minimal long-term modification. Pallidal programming for dystonia may be complex owing to the gradual onset of benefits and often delayed development of side effects. There is a relative scarcity of evidence-based recommendations for standardized programming methods. This chapter reviews essential factors to consider for appropriate patient selection and discusses strategies for initial and follow-up programming. Finally, the chapter describes the potential short-term and long-term adverse effects, while considering various strategies to mitigate them.


2017 ◽  
Vol 88 (11) ◽  
pp. 960-967 ◽  
Author(s):  
Sara Meoni ◽  
Valérie Fraix ◽  
Anna Castrioto ◽  
Alim Louis Benabid ◽  
Eric Seigneuret ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document